Cargando…
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up
Botulinum toxin A (BoNT/A) is the first-line treatment for idiopathic cervical dystonia (ICD) and is widely used in the clinical setting. To date, scanty data are available on the effectiveness of BoNT in treating acquired cervical dystonia (ACD). Here we present a long-term follow-up of ACD patient...
Autores principales: | Petracca, Martina, Lo Monaco, Maria Rita, Ialongo, Tamara, Di Stasio, Enrico, Cerbarano, Maria Luana, Maggi, Loredana, De Biase, Alessandro, Di Lazzaro, Giulia, Calabresi, Paolo, Bentivoglio, Anna Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813057/ https://www.ncbi.nlm.nih.gov/pubmed/36068376 http://dx.doi.org/10.1007/s00415-022-11343-0 |
Ejemplares similares
-
Subacute onset dystonia in a woman affected by Parkinson’s disease following SARS-COV-2 infection
por: Lo Monaco, Maria Rita, et al.
Publicado: (2020) -
Clinical and genetic characteristics of late‐onset Huntington's disease in a large European cohort
por: Petracca, Martina, et al.
Publicado: (2022) -
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation
por: Janiri, Delfina, et al.
Publicado: (2023) -
Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020) -
Classification of Dystonia
por: di Biase, Lazzaro, et al.
Publicado: (2022)